Evidence map›Paper›PMID 42510529›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Metabolic Reprogramming Associated with Ferroptosis Protection by an Indole-Based Antioxidant in Aβ(25-35)-Treated SH-SY5Y Cells.

Mariapia Vietri, Enza Napolitano, Maria Rosaria Miranda, Carmen Marino, Simona Musella, Veronica Di Sarno, Carmine Ostacolo, Michele Manfra, Pietro Campiglia, Mario Felice Tecce and 5 more

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mariapia VietriDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0009-0001-6471-5246
Enza NapolitanoDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0000-0001-8610-879X
Maria Rosaria MirandaDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0009-0005-8296-1888
Carmen MarinoDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.
Simona MusellaDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0000-0001-8312-4241
Veronica Di SarnoDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0000-0002-1397-5240
Carmine OstacoloDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0000-0003-3715-8680
Michele ManfraDepartment of Health Science, University of Basilicata, Viale dell'Ateneo Lucano 10, 85100 Potenza, Italy.ORCID 0000-0002-3320-972X
Pietro CampigliaDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0000-0002-1069-2181
Mario Felice TecceDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0000-0003-2355-6047
Anna Maria D'UrsiDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.
Ornella MoltedoDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0000-0002-0526-2152
Alessia BertaminoDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.
Tania CiagliaDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0000-0002-6592-4373
Vincenzo VestutoDepartment of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.ORCID 0000-0002-3603-5526

Funding

Ministero dell'università e della ricerca J97G22000400006
6 · The paper itself

Abstract

Ferroptosis has emerged as a critical mechanism linking iron dysregulation, oxidative stress, and neurodegeneration in amyloid-associated pathologies. Building on our previous work, which identified compound 20 as a promising antioxidant and neuroprotective agent, the present study investigates the molecular mechanisms underlying its protective activity against amyloid-induced ferroptosis in human neuroblastoma SH-SY5Y cells exposed to Aβ(25-35). Compound 20 (3-(((4-hydroxybenzyl)(methyl)amino)methyl)-1-methyl-N-(2-(piperazin-1-yl)ethyl)-1H-indole-5-carboxamide) markedly counteracted Aβ(25-35)-induced ferroptotic damage by restoring intracellular glutathione levels, depleting the labile iron pool, and suppressing lipid peroxidation. In parallel, the compound significantly rescued mitochondrial membrane potential and attenuated endoplasmic reticulum (ER) expansion associated with ER stress, thereby preserving cellular homeostasis under oxidative challenge. These protective effects were further corroborated by real-time PCR analysis, which revealed the modulation of key genes involved in the oxidative stress response, endoplasmic reticulum stress, and inflammatory pathways. To gain a systems-level insight into these mechanisms, untargeted

Indexed as

Alzheimeramyloid-β (Aβ)ferroptosisindole nucleusmetabolic reprogrammingoxidative stress

Identifiers

PMID42510529
PMCPMC13404325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.